Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.3%
Mon, 7 Oct 9:41

ASTRAZENECA PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.3%Image source: Chunumunu/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 7% and is presently trading at Rs 7,933.6.

Meanwhile, the BSE HEALTHCARE index is at 43,674.5 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Natco Pharma (up 2.7%) and MAX HEALTHCARE INSTITUTE (up 1.5%).

Jubilant Pharmova (down 2.7%) and ALEMBIC PHARMA (down 1.8%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 4,532.7 to Rs 7,933.6, registering a gain of Rs 3,401.0 (up 75.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,674.5, registering a gain of 53.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 149.1%), SUVEN PHARMACEUTICALS (up 106.3%) and Glenmark Pharma (up 99.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,927.3 (up 0.3%).

The top gainers among the BSE Sensex today are ITC (up 1.7%) and Kotak Bank (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,082.7 (up 0.3%). ITC and Kotak Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 81,927.3, registering a gain of 16,415.2 points (up 25.1%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit fell 121.9% YoY to Rs -118 million for the quarter ended June 2024, compared to a profit of Rs 539 million a year ago. Net sales rose 31.2% to Rs 3,875 million during the period as against Rs 2,955 million in April-June 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 206.9.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.3%". Click here!